NCT02732691 - JENAVALVE AS EFS TRIAL: Pericardial TAVR Aortic Stenosis Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 21, 2016

Primary Completion Date

May 28, 2019

Study Completion Date

April 30, 2024

Conditions

Aortic Valve StenosisHeart Valve DiseasesHeart DiseasesCardiovascular DiseasesVentricular Outflow Obstruction

Interventions

DEVICE

JenaValve Pericardial TAVR System

Transcatheter aortic valve replacement (TAVR) will be performed using the JenaValve Pericardial valve and delivery system.

Trial Locations (13)

Auckland City Hospital, Auckland

Leiden University Medical Center, Leiden

Erasmus University Medical Center, Rotterdam

Waikato Hospital, Hamilton

St. Antonius Hospital, Nieuwegein

Universitätsklinikum Halle, Halle

Columbia University Medical Center, New York

Deutsches Herzzentrum Berlin, Berlin

MedStar Washington Hospital Center, Washington D.C.

Universitäres Herzzentrum Hamburg, Hamburg

Herzzentrum der Universität zu Köln, Cologne

Robert-Bosch-Krankenhaus, Stuttgart

Universitäts-Herzzentrum Freiburg/Bad Krozingen, Freiburg im Breisgau